← SynDRA
POZIOTINIB
SynDRA canonical compound SYN0038230 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | EGFR | ERBB2 | ERBB4 |
| Mechanism of action | EGFR inhibitor |
All known targets
Mechanisms of action (all sources)
- ERBB2 INHIBITOR
- Epidermal growth factor receptor inhibitor
- EGFR INHIBITOR
- ERBB4 INHIBITOR
- ERBB3 INHIBITOR
Cross-references
Synonyms
- HM-781-36B
- HM-781-36
- HM781-36B
- NOV-1201
- NOV-120101
- NOV120101
- UNII-OEI6OOU6IK
- Poziotinib [INN]
- NOV 120101
- HM 781-36B
- Poziotinib [USAN]
- 1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one
- 1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one
- OEI6OOU6IK
- HM 781-36
- MFCD28044290
- 1-[4-[[4-[(3,4-Dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one
- 2-Propen-1-one, 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-
- 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
- 1-[4-({4-[(3,4-DICHLORO-2-FLUOROPHENYL)AMINO]-7-METHOXYQUINAZOLIN-6-YL}OXY)PIPERIDIN-1-YL]PROP-2-EN-1-ONE
- 2-PROPEN-1-ONE, 1-(4-((4-((3,4-DICHLORO-2-FLUOROPHENYL)AMINO)-7-METHOXY-6-QUINAZOLINYL)OXY)-1-PIPERIDINYL)-
- HM-78136B
- Poziotinib [USAN:INN]
- POZIOTINIB [WHO-DD]
- C23H21Cl2FN4O3
- Poziotinib (HM781-36B)
- GTPL7903
- SCHEMBL3391764
- CHEMBL3545154
- DTXSID80148853
- EX-A528
- HMS3673K03
- AMY24248
- BCP08270
- WHO 9736
- BDBM50468247
- NSC783296
- NSC800856
- s7358
Look up POZIOTINIB in the interactive SynDRA portal →